Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name H19
   Synonyms H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2
   Region GRCh38_11:1995176-2001470    Sequence
   Ensembl ENSG00000130600
   RefSeq NR_002196
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name gallbladder cancer
   ICD-0-3 C23.9  
   Methods qPCR, RNAi, Western blot, Luciferase reporter assay etc.
   Sample GBC tissues, cell lines (GBC-SD, EHGB-1 and NOZ)
   Expression Pattern up-regulated
   Function Description

We demonstrated H19 was overexpressed and negatively correlated with miR-342-3p in GBC. H19 silencing down-regulated, whereas over-expression enhanced the expression of miR-342-3p targeting FOXM1 through competitively 'sponging' miR-342-3p. Furthermore, H19 knockdown inhibited both cells invasion and proliferation, but this effects was attenuated by co-transfection of siRNA-H19 and miR-342-3p inhibitor in GBC cells.

   Pubmed ID 27716361
   Year 2016
   Title Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
   External Links
   Links for  H19 GenBank       HGNC       lncrnadb       Noncode
   Links for  gallbladder cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.